Medpace Holdings (MEDP) EBITDA Margin (2015 - 2026)
Medpace Holdings (MEDP) recorded EBITDA Margin of 24.04% in Q3 2026, up 1.48 percentage points from 22.56% a year earlier and up 2.33 percentage points from the prior quarter.
Medpace Holdings (MEDP) EBITDA Margin (2015 - 2026) Analysis & Trends
On a TTM basis, Medpace Holdings' EBITDA Margin came in at 22.35% as of Sep 30, 2026, down 0.35 percentage points year-over-year; for FY2025, it came in at 22.25%, down 0.32 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +2.10 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 22.58% in FY2024 (+3.32 pp), 19.26% in FY2023 (-1.36 pp), 20.62% in FY2022 (+1.39 pp) and 19.23% in FY2021 (-0.92 pp).
- The Q3 2026 figure is the highest quarterly EBITDA Margin since Q4 2024.
- On a year-over-year basis, EBITDA Margin rose in four of the last eight quarters, with an average year-over-year change of +0.62 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 5.85 percentage points in Q4 2024, against a drop of 3.76 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at 21.71% (Q2 2026), 21.00% (Q1 2026) and 22.64% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.58 Bn | 33.96 Bn | 1.50 Bn | 20.28% |
| 2 | Medpace Holdings | 18.13 Bn | 15.77 Bn | 223.89 Mn | 24.04% |
| 3 | Charles River Laboratories International | 16.15 Bn | 15.39 Bn | 363.37 Mn | 18.64% |
| 4 | Icon | 15.71 Bn | 12.48 Bn | 491.83 Mn | 14.73% |
| 5 | Fortrea Holdings | 1.93 Bn | 1.22 Bn | 139.50 Mn | 5.06% |
| 6 | Ginkgo Bioworks Holdings | 627.55 Mn | -134.53 Mn | 18.44 Mn | -229.38% |
| 7 | Evotec SE | 540.45 Mn | -1.07 Bn | - | - |
| 8 | Champions Oncology | 68.48 Mn | 44.13 Mn | 7.70 Mn | -0.62% |
| 9 | MindWalk Holdings | 51.38 Mn | 15.04 Mn | 1.61 Mn | -152.92% |
| 10 | Natural Alternatives International | 6.45 Mn | -21.63 Mn | 1.73 Mn | -34.75% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 24.04% |
| Jun 30, 2026 | 21.71% |
| Mar 31, 2026 | 21.00% |
| Dec 31, 2025 | 22.64% |
| Sep 30, 2025 | 22.56% |
| Jun 30, 2025 | 22.10% |
| Mar 31, 2025 | 21.56% |
| Dec 31, 2024 | 24.76% |
| Sep 30, 2024 | 22.46% |
| Jun 30, 2024 | 21.28% |
| Mar 31, 2024 | 21.73% |
| Dec 31, 2023 | 18.92% |
| Sep 30, 2023 | 18.64% |
| Jun 30, 2023 | 18.42% |
| Mar 31, 2023 | 21.23% |
| Dec 31, 2022 | 20.89% |
| Sep 30, 2022 | 21.79% |
| Jun 30, 2022 | 18.73% |
| Mar 31, 2022 | 20.94% |
| Dec 31, 2021 | 19.55% |
Medpace Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MEDP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MEDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MEDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();